Literature DB >> 2394779

Growth hormone secretion in pubertal age patients with Turner's syndrome.

R Lanes1, S Brito, M Suniaga, G Moncada, M Borges.   

Abstract

GH levels were measured every 30 min during sleep over 9 h in 10 patients with Turner's syndrome ranging in age from 10.6-18.9 yr (mean, 15.0 +/- 2.7 yr) and in 12 controls matched for bone age, all of whom had normal GH responses to an orally administered dose of clonidine. We found no significant difference in the mean 9-h overnight GH concentration between groups. The overnight GH concentration was 3.8 +/- 2.2 micrograms/L (mean +/- SD) in Turner's syndrome patients and 4.5 +/- 2.4 micrograms/L in the control group. Total GH output (205.4 +/- 118.7 vs. 251.4 +/- 122.0 U), total number of nocturnal GH pulses (2.4 +/- 0.8 vs. 2.9 +/- 0.7), and mean peak GH response during nocturnal sampling (13.0 +/- 7.4 vs. 13.2 +/- 3.3 micrograms/L) were not different in the children with Turner's syndrome and the controls. We conclude that pubertal age patients with Turner's syndrome secrete GH normally and do not have any abnormality in GH regulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394779     DOI: 10.1210/jcem-71-3-770

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.

Authors:  K Hanew; A Tanaka; A Utsumi
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

2.  Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.

Authors:  T C Sas; S M de Muinck Keizer-Schrama; T Stijnen; A van Teunenbroek; A C Hokken-Koelega; J J Waelkens; G G Massa; T Vulsma; W J Gerver; H M Reeser; H E Delemarre-van de Waal; M Jansen; S L Drop
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.